← Insiders

FTV

Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.

Research, not advice.

À propos

Fortive Corporation

Nom
Fortive Corporation
Secteur
Technology
Industrie
Hardware, Equipment & Parts
Bourse
NYSE
Capitalisation
$18.2B
Employés
10,000
PDG
Olumide O. Soroye
Site web
https://www.fortive.com
Marché
AMEDOVIEXIRITTITW

Fortive Corporation is a global industrial technology company that specializes in the conception, development, manufacturing, marketing, and servicing of sophisticated professional and engineered products, as well as software platforms and associated services. Its Intelligent Operating Solutions division aims to boost efficiency and safety in operations. This segment delivers a variety of offerings, including advanced tools for ensuring equipment reliability, comprehensive enterprise software for managing environmental, health, safety, and quality (EHSQ) compliance, and specialized software for the entire lifecycle of facilities and assets. It also provides solutions for pre-construction planning and procurement, robust professional testing instruments, precise calibration tools for electrical, pressure, and temperature measurements, and portable devices for gas detection. These products and services cater to diverse industries such as manufacturing, process industries, healthcare, utilities and power generation, communications, and electronics. Key brands within this segment include ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL. The company's Precision Technologies segment focuses on delivering critical measurement and control solutions. Its portfolio encompasses electrical testing and measurement instruments and related services, high-performance energetic material devices, and advanced sensor and control system solutions. These technologies are crucial for demanding sectors like power and energy management, medical equipment manufacturing, food and beverage production, aerospace and defense, off-highway vehicles, electronics, semiconductor fabrication, and various other industrial applications. This segment markets its offerings under brands such as ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX. Fortive's Advanced Healthcare Solutions division provides a comprehensive suite of hardware, software, and services specifically designed for the healthcare sector. This includes solutions for reprocessing and tracking medical instruments and devices, specialized biomedical testing tools, systems for radiation safety monitoring, and asset management services. Additionally, it offers subscription-based surgical inventory management platforms that optimize inventory and ensure regulatory adherence, alongside expert technical, analytical, and compliance services focused on determining radiation exposure. Brands in this segment include ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD. Established in 2015, Fortive Corporation maintains its corporate headquarters in Everett, Washington.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

Decouvert par les declarations du Congres

Insiders
—
Total bought
—

Avg buy (VWAP, 90d window) —

Total sold
$533,493

Avg sell (VWAP, 90d window) $61.59 vs last close —

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

Last activity
—
Last synced
2026-10-06 10:56:08 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-08-10 Underwood Peter C Sell · S 8,662 $61.59 $533,493 Form 4

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

Date Member Side Amount range Filing
2026-07-07 Ro Khanna Buy $1,001 - $15,000 Filing

Recent trades

DateRepresentativeTypeAmount
2026-07-07Ro KhannaPurchase$1,001 - $15,000
2025-09-30Gilbert Ray CisnerosSale (Full)$15,001 - $50,000
2025-09-29Ro KhannaPurchase$1,001 - $15,000
2025-09-22Gilbert Ray CisnerosSale (Partial)$1,001 - $15,000
2025-09-12Gilbert Ray CisnerosSale (Partial)$1,001 - $15,000
2025-08-26Gilbert Ray CisnerosSale (Partial)$1,001 - $15,000
2025-07-10Lisa C. McClainSale (Full)$1,001 - $15,000
2025-06-17Lisa C. McClainPurchase$1,001 - $15,000
2025-04-10Thomas KeanSale (Full)$1,001 - $15,000
2025-04-08Robert P. BresnahanPurchase$1,001 - $15,000
2025-01-07Gilbert Ray CisnerosPurchase$1,001 - $15,000
2025-01-06Emily RandallSale (Full)$1,001 - $15,000
2024-11-04Thomas KeanPurchase$1,001 - $15,000
2024-09-09Ro KhannaPurchase$1,001 - $15,000
2024-09-04John JamesSale (Full)$1,001 - $15,000
2024-08-02Thomas KeanPurchase$1,001 - $15,000
2024-01-10Ro KhannaPurchase$1,001 - $15,000
2023-11-10John JamesPurchase$1,001 - $15,000
2023-11-03Ro KhannaSale$1,001 - $15,000
2023-10-31Ro KhannaSale$1,001 - $15,000
2023-10-26Ro KhannaSale$15,001 - $50,000
2023-10-10Ro KhannaPurchase$1,001 - $15,000
2023-08-29Ro KhannaPurchase$1,001 - $15,000
2023-08-03Ro KhannaSale$1,001 - $15,000
2023-06-29Ro KhannaSale$1,001 - $15,000
2023-06-26Ro KhannaSale$1,001 - $15,000
2023-06-21Daniel GoldmanSale (Full)$1,001 - $15,000
2023-03-30Ro KhannaPurchase$1,001 - $15,000
2022-07-19Ro KhannaPurchase$1,001 - $15,000
2022-06-17Ro KhannaPurchase$1,001 - $15,000
2022-05-23Ro KhannaPurchase$1,001 - $15,000
2022-05-10Ro KhannaSale$1,001 - $15,000
2022-04-21Ro KhannaPurchase$1,001 - $15,000
2022-04-11Ro KhannaSale$1,001 - $15,000
2022-02-17Ro KhannaPurchase$1,001 - $15,000
2022-02-14Ro KhannaSale$1,001 - $15,000
2022-01-21Ro KhannaSale$1,001 - $15,000
2022-01-20Ro KhannaPurchase$1,001 - $15,000
2022-01-11Ro KhannaSale$1,001 - $15,000
2021-04-23Kurt SchraderSale (Full)$1,001 - $15,000
2020-12-11Susie LeeSale (Full)$1,001 - $15,000
2020-10-19Susie LeeSale (Partial)$1,001 - $15,000
2020-04-02Dean PhillipsSale (Partial)$1,001 - $15,000
2019-12-18John B. LarsonSale (Full)$1,001 - $15,000
2019-10-03Susie LeeSale (Partial)$1,001 - $15,000
2019-09-06Susie LeeSale (Partial)$1,001 - $15,000
2019-07-12Susie LeePurchase$1,001 - $15,000
2019-06-25Susie LeePurchase$1,001 - $15,000
2019-02-27Susie LeePurchase$1,001 - $15,000
2019-01-04Dean PhillipsPurchase$1,001 - $15,000

Signal

Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.

FTV presents a deeply concerning financial profile with a sub-1.0 current ratio (0.71), rising leverage, and weakening cash flow coverage, signaling acute liquidity stress.

The first sentence of the analysis written for FTV on 2026-10-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Neutral signal Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
  • Congress Unavailable or mixed. 1 purchase disclosure year to date, a thin reading
  • Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
  • Timing Unavailable or mixed. No stored price series
  • Financial indicators Unavailable or mixed. Current ratio 0.71 · operating margin 18% — readings disagree

Market snapshot

Financial ratios

MetricTrend2025-12-312024-12-312023-12-312022-12-312021-12-31
Gross Profit Margin61.0%59.9%59.3%57.7%57.3%
Ebit Margin17.0%18.0%18.4%16.7%14.9%
Ebitda Margin23.3%26.7%25.9%24.7%22.4%
Operating Profit Margin17.7%18.9%18.7%17.3%15.8%
Pretax Profit Margin14.7%15.6%16.3%15.0%12.9%
Continuous Operations Profit Margin12.5%13.4%14.3%13.0%11.7%
Net Profit Margin11.3%13.4%14.3%13.0%11.6%
Bottom Line Profit Margin11.3%13.4%14.3%13.0%10.9%
Current Ratio0.7151.1582.0500.9080.677
Quick Ratio0.5850.9151.7500.7110.539
Solvency Ratio0.1720.2020.2010.1970.144
Cash Ratio0.1670.3631.0540.2600.221
Price To Earnings Ratio31.54923.64022.55722.84035.055
Price To Earnings Growth Ratio-1.178-8.3081.4060.780-0.546
Forward Price To Earnings Growth Ratio-1.178-8.3081.4060.780-0.546
Price To Earnings Diluted Ratio31.73023.94122.83523.16735.270
Price To Earnings Diluted Growth Ratio-1.208-8.3111.4040.821-0.568
Price To Book Ratio2.7071.9361.8961.7822.109
Price To Sales Ratio3.3973.1663.2252.9623.818
Price To Free Cash Flow Ratio17.86014.02915.70114.29322.022
Price To Operating Cash Flow Ratio16.12712.92214.45113.24220.876
Debt To Assets Ratio0.2730.2280.2250.2150.252
Debt To Equity Ratio0.4970.3810.3690.3530.436
Debt To Capital Ratio0.3320.2760.2700.2610.303
Long Term Debt To Capital Ratio0.2630.2460.2610.1890.160
Financial Leverage Ratio1.8191.6701.6391.6411.731
Working Capital Turnover Ratio-35.8375.5797.441-8.03527.219
Operating Cash Flow Ratio0.4820.6820.7560.4780.259
Operating Cash Flow Sales Ratio0.2110.2450.2230.2240.183
Free Cash Flow Operating Cash Flow Ratio0.9030.9210.9200.9260.948
Debt Service Coverage Ratio1.0662.89111.7091.2010.494
Interest Coverage Ratio7.5437.7019.18010.2278.057
Short Term Operating Cash Flow Coverage Ratio1.2044.0580.0001.3040.447
Operating Cash Flow Coverage Ratio0.3380.3940.3550.3810.232
Capital Expenditure Coverage Ratio10.30612.68112.55713.60319.222
Dividend Paid And Capex Coverage Ratio5.4906.5926.4526.6735.275
Dividend Payout Ratio0.1590.1340.1180.1320.217
Enterprise Value Multiple16.91013.67913.67313.89219.885

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 61.0% ▲1.1% ▲1.9%
Ebit Margin 17.0% ▼-1.0% ▲0.0%
Ebitda Margin 23.3% ▼-3.4% ▼-1.3%
Operating Profit Margin 17.7% ▼-1.2% ▲0.0%
Pretax Profit Margin 14.7% ▼-0.9% ▼-0.2%
Continuous Operations Profit Margin 12.5% ▼-0.9% ▼-0.5%
Net Profit Margin 11.3% ▼-2.1% ▼-1.4%
Bottom Line Profit Margin 11.3% ▼-2.1% ▼-1.3%
Current Ratio 0.715 ▼-0.443 ▼-0.387
Quick Ratio 0.585 ▼-0.330 ▼-0.315
Solvency Ratio 0.172 ▼-0.030 ▼-0.012
Cash Ratio 0.167 ▼-0.196 ▼-0.246
Price To Earnings Ratio 31.549 ▲7.908 ▲4.420
Price To Earnings Growth Ratio -1.178 ▲7.130 ▲0.391
Forward Price To Earnings Growth Ratio -1.178 ▲7.130 ▲0.391
Price To Earnings Diluted Ratio 31.730 ▲7.789 ▲4.341
Price To Earnings Diluted Growth Ratio -1.208 ▲7.103 ▲0.365
Price To Book Ratio 2.707 ▲0.770 ▲0.621
Price To Sales Ratio 3.397 ▲0.231 ▲0.083
Price To Free Cash Flow Ratio 17.860 ▲3.831 ▲1.079
Price To Operating Cash Flow Ratio 16.127 ▲3.204 ▲0.603
Debt To Assets Ratio 0.273 ▲0.045 ▲0.035
Debt To Equity Ratio 0.497 ▲0.116 ▲0.090
Debt To Capital Ratio 0.332 ▲0.056 ▲0.044
Long Term Debt To Capital Ratio 0.263 ▲0.017 ▲0.040
Financial Leverage Ratio 1.819 ▲0.149 ▲0.119
Working Capital Turnover Ratio -35.837 ▼-41.416 ▼-35.110
Operating Cash Flow Ratio 0.482 ▼-0.200 ▼-0.049
Operating Cash Flow Sales Ratio 0.211 ▼-0.034 ▼-0.006
Free Cash Flow Operating Cash Flow Ratio 0.903 ▼-0.018 ▼-0.021
Debt Service Coverage Ratio 1.066 ▼-1.825 ▼-2.406
Interest Coverage Ratio 7.543 ▼-0.158 ▼-0.999
Short Term Operating Cash Flow Coverage Ratio 1.204 ▼-2.854 ▼-0.198
Operating Cash Flow Coverage Ratio 0.338 ▼-0.056 ▼-0.002
Capital Expenditure Coverage Ratio 10.306 ▼-2.375 ▼-3.368
Dividend Paid And Capex Coverage Ratio 5.490 ▼-1.102 ▼-0.606
Dividend Payout Ratio 0.159 ▲0.026 ▲0.007
Enterprise Value Multiple 16.910 ▲3.231 ▲1.302

Key metrics

MetricTrend20252024202320222021
Market cap$17.47B$19.73B$19.56B$17.26B$20.06B
Enterprise value$20.30B$22.79B$21.48B$19.97B$23.39B
EV / Sales3.95x3.66x3.54x3.43x4.45x
EV / Op. cash flow18.74x14.93x15.87x15.32x24.34x
EV / Free cash flow20.75x16.21x17.24x16.54x25.67x
EV / EBITDA16.91x13.68x13.67x13.89x19.89x
Net debt / EBITDA2.36x1.84x1.22x1.89x2.83x
Current ratio0.71x1.16x2.05x0.91x0.68x
Income quality1.87x1.83x1.56x1.73x1.56x
Graham number$29$40$40$36$33
Graham net-net-$13-$14-$11-$13-$15
Tax burden76.8%85.9%87.4%86.5%89.8%
Interest burden86.2%86.4%88.9%89.9%86.8%
Working capital-$640.9M$353.9M$1.88B-$250.1M-$1.20B
Invested capital$9.12B$14.28B$14.60B$12.71B$12.24B
Return on assets4.9%4.9%5.1%4.8%3.7%
Operating ROA6.3%6.9%6.9%6.2%5.1%
Return on tangible assets25.7%23.7%18.7%22.5%17.8%
Return on equity9.0%8.2%8.4%7.8%6.4%
Return on invested capital7.4%6.7%6.5%6.1%5.0%
Return on capital employed9.6%8.0%7.5%7.6%6.5%
Earnings yield3.3%4.2%4.4%4.4%3.0%
Free cash flow yield5.6%7.1%6.4%7.0%4.5%
Capex / Op. cash flow9.7%7.9%8.0%7.4%5.2%
Capex / Depreciation24.0%22.1%23.6%20.6%12.6%
Capex / Sales2.0%1.9%1.8%1.6%1.0%
SG&A / Sales36.6%34.3%34.0%33.6%34.7%
R&D / Sales6.7%6.6%6.6%6.9%6.8%
Stock comp / Sales2.3%1.8%1.9%1.6%1.5%
Intangibles / Total assets80.8%79.3%72.6%78.9%79.2%
Days sales outstanding49d55d58d60d65d
Days payables outstanding79d99d90d92d91d
Operating cycle102d135d137d140d148d
Cash conversion cycle22d36d47d47d57d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▼-11.5%EV / Sales ▲+7.9%EV / EBITDA ▲+23.6%EV / Op. cash flow ▲+3.811Earnings yield ▼-0.009Graham number ▼-10.586
Profitability
Return on equity ▲+0.008Return on assets +0.000Return on invested capital ▲+0.008Return on capital employed ▲+0.016Operating ROA ▼-0.006Income quality ▲+0.037Tax burden ▼-0.091
Efficiency
Days sales outstanding ▼-6.854Days payables outstanding ▼-19.539Operating cycle ▼-33.325Cash conversion cycle ▼-13.786Capex / Sales ▲+0.001R&D / Sales +0.000
Balance-sheet strength
Current ratio ▼-0.443Net debt / EBITDA ▲+0.519Working capital ▼-994800000.000Invested capital ▼-5167400000.000Intangibles / Total assets ▲+0.015

Change over 5 years

Valuation
Market cap ▼-12.9%EV / Sales ▼-11.3%EV / EBITDA ▼-15.0%EV / Op. cash flow ▼-5.595Earnings yield ▲+0.003Graham number ▼-3.712
Profitability
Return on equity ▲+0.026Return on assets ▲+0.012Return on invested capital ▲+0.024Return on capital employed ▲+0.031Operating ROA ▲+0.012Income quality ▲+0.305Tax burden ▼-0.130
Efficiency
Days sales outstanding ▼-16.094Days payables outstanding ▼-11.384Operating cycle ▼-46.414Cash conversion cycle ▼-35.030Capex / Sales ▲+0.011R&D / Sales ▼-0.001
Balance-sheet strength
Current ratio ▲+0.038Net debt / EBITDA ▼-0.468Working capital ▲+559100000.000Invested capital ▼-3122100000.000Intangibles / Total assets ▲+0.016

Employee count

Peer market caps

Recent news